Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.
Alex H GiffordJulie L SanvilleMeghana SatheSonya L HeltsheChristopher H GossPublished in: Pediatric pulmonology (2021)
Males and females with cystic fibrosis (CF) who used PPIs and females with CF who concurrently used PPIs and H2RAs had lower Hgb levels than never-users of ASMs of the same sex in the CFFPR from 2011 to 2017.